Markets

Pacira Pharmaceuticals (PCRX) Falls: Stock Goes Down 9.7% - Tale of the Tape

Pacira Pharmaceuticals, Inc. ( PCRX ) saw a big move last session, as the company's shares fell by nearly 10% yesterday. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for PCRX as the stock is now up about 8% since Apr 1.

Yesterday, the company received a subpoena from the U.S. Department of Justice, asking the company to produce documents pertaining to marketing and promotional practices for its lead drug Exparel.

The pharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past few weeks and the consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

PCRX currently has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is 0.00%.

Investors interested in the Medical-Drugs industry may consider better-ranked stock like ArQule Inc. ( ARQL ), which carries a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

PACIRA PHARMACT (PCRX): Free Stock Analysis Report

ARQULE INC (ARQL): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

PCRX ARQL

Other Topics

Investing Stocks